Rosacea affects roughly 5% of the adult population worldwide, making it one of the more common chronic skin conditions. A 2024 study of over 50,000 people across 20 countries found that overall prevalence of 5.1%, though estimates in the U.S. and Europe have ranged anywhere from less than 1% to more than 20% depending on how the study was designed and who was surveyed.
Who Gets Rosacea Most Often
Rosacea follows a distinct pattern by age and sex. Women are diagnosed more frequently than men before age 50, but the gap reverses after that. Among people aged 50 to 70, men actually have higher rates. This shift likely reflects both biological changes and the fact that a thickening of the nose (the subtype most associated with rosacea in popular culture) is far more common in men and tends to develop later in life.
The condition is rare in children. Less than 1% of pediatric patients in one large single-center study received a rosacea diagnosis, and a Colombian study found only 1.4% of all rosacea patients were under 20. Most people first notice symptoms in their 30s or 40s.
Rosacea Across Skin Tones
Rosacea has long been considered a condition of fair-skinned people, but that reputation is partly a diagnostic blind spot. In darker skin, the hallmark redness is harder to see, so the condition gets missed more often. A U.S. survey of outpatient visits between 1993 and 2010 found that only 2% of rosacea patients were Black, 2.3% were Asian or Pacific Islander, and 3.9% were Hispanic or Latino. But population-based studies outside the U.S. tell a different story: prevalence in China has been measured between 3.4% and 10.6% depending on the study, and worldwide estimates suggest as many as 40 million people with darker skin tones have rosacea.
In people with very dark skin, rosacea often looks different. Instead of the classic redness and visible blood vessels, it can present as skin-colored bumps. One study of patients with the darkest skin tones found that 60% had bumps without obvious redness, which makes it easy to confuse with acne or other conditions.
The Role of Family History
Genetics play a significant role. In a study of 130 rosacea patients, nearly half (49.2%) had at least one family member with the condition. When researchers examined the extended families of those patients more closely, the familial rate jumped to 69.2%, with an average ratio of about 1.4 affected relatives per patient. If a parent or sibling has rosacea, your own risk is substantially higher than the general population’s.
Eye Involvement Is Surprisingly Common
Many people don’t realize rosacea can affect the eyes. More than 50% of people with rosacea develop some form of ocular symptoms: dryness, grittiness, burning, or visible blood vessels on the whites of the eyes. In about 20% of cases, eye symptoms actually appear before any skin changes, which means some people visit an eye doctor for chronic irritation without anyone connecting it to rosacea.
Most ocular involvement is mild and manageable, but roughly 5% of rosacea patients develop corneal problems that, in rare cases, can threaten vision through ulceration or scarring.
Many Cases Go Undiagnosed
The wide range in published prevalence estimates (from under 1% to over 20% in the U.S. and Europe alone) points to a real problem: there is no blood test or biopsy that definitively confirms rosacea, and diagnosis depends on a clinician recognizing the pattern. People with mild flushing often dismiss it as sensitive skin. Those with darker complexions may never be screened for it. And the ocular form can masquerade as allergies or dry eye for years.
The 5.1% global figure from the 2024 multinational study used dermatologist assessments rather than medical records, which likely captures a more accurate picture than studies relying on insurance codes or self-reporting. Still, given how often rosacea goes unrecognized, particularly in non-white populations and in its eye-only form, the true number of people living with it is almost certainly higher than any single study suggests.
How Prevalence Varies by Region
Geography creates striking differences in the numbers. South Africa and Tunisia have reported prevalence rates around 0.2%, while individual studies in China have found rates as high as 10.6%. A combined survey across China, Malaysia, and Indonesia landed at 0.9%. These gaps don’t necessarily mean rosacea is genuinely rare in some populations. Differences in healthcare access, diagnostic habits, and awareness all shape whether cases get counted. Countries with well-established dermatology networks and lighter-skinned populations tend to report higher numbers simply because the condition gets recognized and recorded more often.